4//SEC Filing
INDEVUS PHARMACEUTICALS INC 4
Accession 0001181431-04-046459
CIK 0000854222operating
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 7:37 PM ET
Size
14.5 KB
Accession
0001181431-04-046459
Insider Transaction Report
Form 4
SANDAGE BOBBY W PHD
Executive Vice President
Transactions
- Award
Common Stock, $.001 par value
2004-10-01$2.38/sh+10,000$23,750→ 68,039 total - Exercise/Conversion
Employee Stock Option (right to buy)
2004-10-01$2.38/sh−10,000$23,750→ 452,500 totalExercise: $2.38From: 2004-10-01Exp: 2010-04-05→ Common Stock, $.001 par value (10,000 underlying) - Sale
Common Stock, $.001 par value
2004-10-01$7.13/sh−10,000$71,300→ 58,039 total - Sale
Common Stock, $.001 par value
2004-10-01$7.13/sh−15,000$106,950→ 58,039 total - Exercise/Conversion
Employee Stock Option (right to buy)
2004-10-01$2.38/sh−15,000$35,625→ 437,500 totalExercise: $2.38From: 2004-10-01Exp: 2010-04-05→ Common Stock, $.001 par value (15,000 underlying) - Award
Common Stock, $.001 par value
2004-10-01$2.38/sh+15,000$35,625→ 73,039 total
Footnotes (7)
- [F1]Represents exercise of stock options granted pursuant to the Company's 1994 Long-term Incentive Plan.
- [F2]Represents exercise of stock options granted pursuant to the Company's 2000 Stock Option Plan.
- [F3]Represents shares acquired pursuant to exercise of stock options granted pursuant to the Company's 1994 Long-term Incentive Plan.
- [F4]Represents sale of common stock acquired pursuant to the Company's 1994 Long-term Incentive Plan.
- [F5]Represents shares acquired pursuant to exercise of stock options granted pursuant to the Company's 2000 Stock Option Plan.
- [F6]Represenst sale of stock acquired pursuant to the Company's 2000 Stock Option Plan.
- [F7]Represents sale of securities pursuant to a 10b 5-1 Plan.
Documents
Issuer
INDEVUS PHARMACEUTICALS INC
CIK 0000854222
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000854222
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 7:37 PM ET
- Size
- 14.5 KB